In what represents a significant setback for public health and biomedical science, the Trump administration has surreptitiously dismantled the Healthcare Infection Control Practices Advisory Committee (HICPAC) – a key player in the United States’ defense against infectious diseases. HICPAC, a federal advisory body under the aegis of the Centers for Disease Control and Prevention (CDC), has been instrumental for more than three decades in shaping the national infection prevention guidelines that safeguard hospital environments, help contain outbreaks and ensure uniform health protections across all healthcare settings.
This sudden dissolution comes shrouded as part of a larger federal workforce reduction as mandated by President Trump’s executive order. Far from being just a bureaucratic reorganization, the obliteration of HICPAC and similar scientific bodies reflects a growing pattern of science denial and overlooking public health. This is a disturbing trend that risks undoing decades of hard-won progress in infection prevention and disease control.
Established in 1991, HICPAC was responsible for issuing over 540 infection control mandates, 90% of which the CDC fully implemented. These have defined the national standards for several areas – hand hygiene, environmental decontamination, surgical field sterility, and the use of personal protective equipment (PPE). Beyond recommendations, HICPAC influenced Medicare and Medicaid participation requirements, Joint Commission accreditation standards, and state-level public health regulations. Its guidelines helped mold the very framework of infection control across the healthcare system in America.
The elimination of this unified, scientifically-informed playbook leaves healthcare institutions without a clear guide. This risks state and local health departments diverging in infection control protocols, leading to potential confusion and jeopardizing patient and worker safety. The vacuum left by the absence of a centralized advisory body allows local and state governments to establish their own infection control guidelines, which are likely to be driven more by politics than by evidence.
The abolition of HICPAC is not an isolated occurrence but a part of a larger assault on scientific and public health initiatives by the Trump administration. The repercussions are far from merely financial but resonate with a systematic disregard for expert opinion, biomedical science, and public accountability.
The abolition has direct consequences for everyday Americans. HICPAC’s guidelines played a significant role in preventing the spread of infections like MRSA, C. difficile, and drug-resistant bacteria in senior and long-term care facilities. Without this committee, these infection prevention standards may stagnate, and nursing homes may be left relying on obsolete or inconsistent practices.
HICPAC was instrumental in readiness plans for threats ranging from Ebola to COVID-19. Its absence impedes the CDC’s ability to rapidly update guidelines in response to emerging threats, potentially causing confusion among frontline clinicians and delaying the implementation of life-saving precautions. This isn’t just about bureaucratic restructuring – it impacts the delivery of safe, evidence-based care at your local hospital. It impacts the safety of your child undergoing surgery, your spouse on dialysis, or your elderly parent in a care facility.
With global health threats, from antibiotic resistance to future pandemics, becoming increasingly complex, the U.S. needs more, not less, scientific guidance and coordination. Stripping institutions that convert research into practice neither makes us leaner nor more efficient. It renders us slower to respond, less prepared, and more susceptible. Upholding science-based policy is now more crucial than ever, and we must not relent.